Memantine Improves Cognition and Reduces Alzheimer’s-Like Neuropathology in Transgenic Mice

Memantine is an N-methyl-d-aspartate receptor antagonist that is approved for the treatment of moderate to severe Alzheimer’s disease (AD). In this study, three groups of triple-transgenic (3xTg-AD) mice with differing levels of AD-like pathology (6, 9, and 15 months of age) were treated for 3 month...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Martinez-Coria, Hilda, Green, Kim N., Billings, Lauren M., Kitazawa, Masashi, Albrecht, Miriam, Rammes, Gerhard, Parsons, Chris G., Gupta, Sandeep, Banerjee, Pradeep, LaFerla, Frank M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Investigative Pathology 2010
Assuntos:
Regular Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2808092/
https://ncbi.nlm.nih.gov/pubmed/20042680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2010.090452
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados